AGP Executive Report
Last update: 7 hours agoHIV Prevention Access: Gilead and PAHO agreed to speed access to twice-yearly lenacapavir for HIV prevention (PrEP) across Latin America and the Caribbean, using PAHO’s regional procurement pathway to expand options for 14 countries including Peru. Public Health Tech: Apple says hypertension notifications on Apple Watch Series 12 and Ultra 4 aren’t available in 33 regions due to pending regulatory clearances—important for Peru-bound buyers watching feature rollout. Health & Wellness (Global): A new synthetic yellow fever vaccine licensing deal (VaxThera–Codagenix) targets modern manufacturing and could shape future vaccine supply. Travel Safety: Americans traveling to Peru were warned about crime and security risks, including robberies and drugged drinks, highlighting ongoing traveler-health concerns. Local Health Context: Peru’s historic Chan Chan heritage faces El Niño-driven weather threats, raising indirect health risks via disruption and environmental stress.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
